Anavex Life Sciences Corp (AVXL)

[nidan7500]

Suggests Moving the horizon? Wouldn't it be refreshing to have a regulatory body move something in?

To maximize the lessons learned through the program, the FDA is committed to sharing innovative CID approaches considered through this pilot program with the broader scientififc community through public presentations, including trial designs for drugs that have not yet been approved by FDA. The hope is that these pilot trials will inform future trial designs by companies who did not participate in a pilot program meeting. Meetings under the pilot program will be conducted through the fall of 2023.

https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm618829.htm

Good to see suggested levels of open thinking and perhaps better collaboration but it suggests more time and money being spent at regulatory interfaces. We'll see.